An allosteric inhibitor of Mycobacterium tuberculosis ArgJ: Implications to a novel combinatorial therapy

Avadhesha Surolia(National Institute of Immunology)

EMBO Molecular Medicine

February 26, 2018

10.15252/emmm.201708038

Cited by 46

Related Papers

Ligand Specificity of Group I Biotin Protein Ligase of Mycobacterium tuberculosis

|PLoS ONE|2008|36

Activation and inhibition of DNA methyltransferases by S-adenosyl-l-homocysteine analogues

|Bioorganic & Medicinal Chemistry|2007|32

Structural Insights into the Acyl Intermediates of the Plasmodium falciparum Fatty Acid Synthesis Pathway

|Journal of Biological Chemistry|2009|28

Auto-Reactive Th17-Cells Trigger Obsessive-Compulsive-Disorder Like Behavior in Mice With Experimental Autoimmune Encephalomyelitis

|Frontiers in Immunology|2018|20

Simvastatin Induced Neurite Outgrowth Unveils Role of Cell Surface Cholesterol and Acetyl CoA Carboxylase in SH-SY5Y Cells

|PLoS ONE|2013|12